0001636282-26-000001.txt : 20260113 0001636282-26-000001.hdr.sgml : 20260113 20260113212534 ACCESSION NUMBER: 0001636282-26-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260109 FILED AS OF DATE: 20260113 DATE AS OF CHANGE: 20260113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: King-Jones Heidy CENTRAL INDEX KEY: 0001794898 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37722 FILM NUMBER: 26531330 MAIL ADDRESS: STREET 1: C/O SPYRE THERAPEUTICS, INC. STREET 2: 221 CRESCENT STREET, BLDG 23, SUITE 105 CITY: WALTHAM STATE: MA ZIP: 02453 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Spyre Therapeutics, Inc. CENTRAL INDEX KEY: 0001636282 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 464312787 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 221 CRESCENT STREET STREET 2: BUILDING 23, SUITE 105 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 6176515940 MAIL ADDRESS: STREET 1: 221 CRESCENT STREET STREET 2: BUILDING 23, SUITE 105 CITY: WALTHAM STATE: MA ZIP: 02453 FORMER COMPANY: FORMER CONFORMED NAME: Aeglea BioTherapeutics, Inc. DATE OF NAME CHANGE: 20150311 4 1 wk-form4_1768357531.xml FORM 4 X0508 4 2026-01-09 0 0001636282 Spyre Therapeutics, Inc. SYRE 0001794898 King-Jones Heidy 221 CRESCENT STREET, BUILDING 23, SUITE 105 WALTHAM MA 02453 0 1 0 0 See Remarks 0 Stock Option (Right to Buy) 30.61 2026-01-09 4 A 0 140000 0 A 2036-01-09 Common Stock 140000 140000 D This option represents a right to purchase 140,000 shares of the Issuer's common stock, which will vest in equal monthly installments over four years, subject to the Reporting Person's continued employment with the Issuer at each vesting date. Chief Legal Officer and Corporate Secretary /s/ Heidy King-Jones 2026-01-13